Investors & Partners Samsara BioCapital actively funds and co-leads rounds with leading life science investors and strategic players, indicating strong collaboration potential with biotech sponsors, CROs, and pharma partners for syndicated deals.

Portfolio Expansion Recent investments across gene therapy, neurology, and ocular disease indicate Samsara’s interest in diverse biotech modalities; approach the firm with high-potential asset opportunities and co-development models to fit their thesis.

Clinical Development Track their portfolio’s clinical milestones and partner-ready assets; engage with teams focused on late-preclinical to Phase 1/2 programs where Samsara has shown willingness to invest in round-raising alongside other investors.

Strategic Value Position opportunities around platform technologies, brain-penetrant compounds, or precision therapies that align with Samsara’s mission to translate science into transformative medicines for patients, highlighting potential synergies with existing portfolio companies.

Geographic & Ecosystem Given their cross-portfolio international collaborations (Swiss, U.S. investments) and partnerships with notable groups, propose strategic co-investments, advisory roles, or ecosystem partnerships that leverage global networks and accelerate portfolio exits.